Northstar Select^®

Therapy Selection

Northstar Select^® is a liquid biopsy test that evaluates 84 genes (82 genes for single nucleotide variants (SNVs) / indels, 19 genes for copy number amplification, 5 genes for copy number loss and 9 genes for fusions) using next generation sequencing (NGS). This test can provide insight into what therapies may be appropriate for a patient with stage III or IV cancer.

Select Test Information Sheet

Select Sample Report

Northstar Test Requisition Form

Northstar Select & Response Brochure

Learn More